[1]
J. Rautiola, T. Utriainen, K. Peltola, H. Joensuu, and P. Bono, “Pazopanib after sunitinib failure in patients with metastatic renal cell carcinoma”, AO, vol. 53, no. 1, pp. 113–118, Jan. 2014.